vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and LINKBANCORP, Inc. (LNKB). Click either name above to swap in a different company.
LINKBANCORP, Inc. is the larger business by last-quarter revenue ($46.0M vs $38.3M, roughly 1.2× ImmunityBio, Inc.). LINKBANCORP, Inc. runs the higher net margin — 6.4% vs -161.8%, a 168.2% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 7.3%). LINKBANCORP, Inc. produced more free cash flow last quarter ($23.8M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
IBRX vs LNKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $46.0M |
| Net Profit | $-61.9M | $2.9M |
| Gross Margin | 99.0% | — |
| Operating Margin | -169.0% | 8.5% |
| Net Margin | -161.8% | 6.4% |
| Revenue YoY | 407.0% | 7.3% |
| Net Profit YoY | -4.7% | -61.2% |
| EPS (diluted) | $-0.06 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $46.0M | ||
| Q3 25 | $32.1M | $44.8M | ||
| Q2 25 | $26.4M | $42.3M | ||
| Q1 25 | $16.5M | $53.4M | ||
| Q4 24 | $7.6M | $42.9M | ||
| Q3 24 | $6.1M | $42.9M | ||
| Q2 24 | — | $41.3M | ||
| Q1 24 | — | $40.5M |
| Q4 25 | $-61.9M | $2.9M | ||
| Q3 25 | $-67.3M | $7.8M | ||
| Q2 25 | $-92.6M | $7.4M | ||
| Q1 25 | $-129.6M | $15.3M | ||
| Q4 24 | $-59.2M | $7.6M | ||
| Q3 24 | $-85.7M | $7.1M | ||
| Q2 24 | — | $5.8M | ||
| Q1 24 | — | $5.7M |
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -169.0% | 8.5% | ||
| Q3 25 | -173.5% | 22.3% | ||
| Q2 25 | -269.8% | 22.4% | ||
| Q1 25 | -390.1% | 36.0% | ||
| Q4 24 | -919.0% | 22.6% | ||
| Q3 24 | -1314.3% | 21.3% | ||
| Q2 24 | — | 18.0% | ||
| Q1 24 | — | 18.1% |
| Q4 25 | -161.8% | 6.4% | ||
| Q3 25 | -209.8% | 17.5% | ||
| Q2 25 | -350.3% | 17.5% | ||
| Q1 25 | -784.9% | 28.7% | ||
| Q4 24 | -783.4% | 17.7% | ||
| Q3 24 | -1404.0% | 16.5% | ||
| Q2 24 | — | 14.1% | ||
| Q1 24 | — | 14.1% |
| Q4 25 | $-0.06 | $0.08 | ||
| Q3 25 | $-0.07 | $0.21 | ||
| Q2 25 | $-0.10 | $0.20 | ||
| Q1 25 | $-0.15 | $0.41 | ||
| Q4 24 | $-0.08 | $0.21 | ||
| Q3 24 | $-0.14 | $0.19 | ||
| Q2 24 | — | $0.16 | ||
| Q1 24 | — | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $52.3M |
| Total DebtLower is stronger | — | $177.3M |
| Stockholders' EquityBook value | $-500.5M | $306.4M |
| Total Assets | $501.9M | $3.1B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $52.3M | ||
| Q3 25 | $257.8M | $194.2M | ||
| Q2 25 | $153.7M | $155.1M | ||
| Q1 25 | $61.6M | $220.2M | ||
| Q4 24 | $149.8M | $166.1M | ||
| Q3 24 | $130.4M | $191.2M | ||
| Q2 24 | — | $181.7M | ||
| Q1 24 | — | $172.3M |
| Q4 25 | — | $177.3M | ||
| Q3 25 | — | $102.3M | ||
| Q2 25 | — | $102.3M | ||
| Q1 25 | — | $102.7M | ||
| Q4 24 | — | $112.5M | ||
| Q3 24 | — | $102.4M | ||
| Q2 24 | — | $102.3M | ||
| Q1 24 | — | $102.2M |
| Q4 25 | $-500.5M | $306.4M | ||
| Q3 25 | $-524.3M | $305.5M | ||
| Q2 25 | $-570.7M | $298.0M | ||
| Q1 25 | $-591.4M | $294.1M | ||
| Q4 24 | $-489.1M | $280.2M | ||
| Q3 24 | $-745.1M | $277.4M | ||
| Q2 24 | — | $271.4M | ||
| Q1 24 | — | $268.2M |
| Q4 25 | $501.9M | $3.1B | ||
| Q3 25 | $519.0M | $3.1B | ||
| Q2 25 | $402.1M | $2.9B | ||
| Q1 25 | $303.8M | $2.9B | ||
| Q4 24 | $382.9M | $2.9B | ||
| Q3 24 | $364.6M | $2.9B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 0.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $25.3M |
| Free Cash FlowOCF − Capex | $-71.3M | $23.8M |
| FCF MarginFCF / Revenue | -186.2% | 51.7% |
| Capex IntensityCapex / Revenue | 2.4% | 3.2% |
| Cash ConversionOCF / Net Profit | — | 8.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $25.3M | ||
| Q3 25 | $-68.9M | $23.6M | ||
| Q2 25 | $-79.7M | $6.3M | ||
| Q1 25 | $-85.9M | $2.6M | ||
| Q4 24 | $-85.1M | $25.4M | ||
| Q3 24 | $-98.8M | $14.0M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $-771.0K |
| Q4 25 | $-71.3M | $23.8M | ||
| Q3 25 | $-69.6M | $23.2M | ||
| Q2 25 | $-80.8M | $6.1M | ||
| Q1 25 | $-87.0M | $2.2M | ||
| Q4 24 | $-87.3M | $22.6M | ||
| Q3 24 | $-101.6M | $13.1M | ||
| Q2 24 | — | $6.3M | ||
| Q1 24 | — | $-1.2M |
| Q4 25 | -186.2% | 51.7% | ||
| Q3 25 | -217.2% | 51.8% | ||
| Q2 25 | -305.9% | 14.5% | ||
| Q1 25 | -526.9% | 4.2% | ||
| Q4 24 | -1155.4% | 52.6% | ||
| Q3 24 | -1663.2% | 30.5% | ||
| Q2 24 | — | 15.3% | ||
| Q1 24 | — | -3.0% |
| Q4 25 | 2.4% | 3.2% | ||
| Q3 25 | 2.3% | 0.8% | ||
| Q2 25 | 4.1% | 0.4% | ||
| Q1 25 | 6.8% | 0.7% | ||
| Q4 24 | 28.0% | 6.7% | ||
| Q3 24 | 45.7% | 2.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | 8.59× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 3.35× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
